Nasdaq · Healthcare
AGENUS INC (AGEN)
As-reported financials and recent SEC filings for AGENUS INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$114.2M
Net income
$-3.1M
Net margin
-2.7%
Diluted EPS
$0.00
ROE
1.1%
P/E (TTM)
—
Market cap
—
Debt / equity
0.0×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $114.2M | $103.5M | $156.3M | $98.0M | $295.7M |
| Gross profit | — | — | — | $87.5M | — |
| Operating income | $-20.2M | $-120.5M | $-159.5M | $-179.4M | $25.7M |
| Net income | $-3.1M | $-232.3M | $-257.4M | $-230.7M | $-28.7M |
| Diluted EPS | $0.00 | $-10.59 | $-13.75 | $-15.64 | $-0.00 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-07-06
View on EDGAR →42026-06-30
View on EDGAR →8-K2026-06-23
View on EDGAR →42026-06-16
View on EDGAR →42026-06-02
View on EDGAR →42026-05-19
View on EDGAR →8-K2026-05-15
View on EDGAR →DEFA14A2026-05-13
View on EDGAR →Largest Healthcare peers
Go deeper on AGEN
Search AGENUS INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.